PROS1 and COVID-19: In a close relation with hyperinflammation, hypercoagulation and thrombotic events are acknowledged as major complications in COVID-19 and post-COVID-19 patients [43, 44], and they represent rare but challenging adverse effects of S protein mRNA-based vaccines [45].